That is part of the conjecture and supposedly outside review announced tomorrow will reveal that in fact the trial was successful. I did speak with the CEO about problems with delivery mechanism in these type of trials and he said an announcement would be coming soon. My average cost now is 5 cents so not very worried about potential loss here. There is great representation of major Pharma on advisory board.
Note NVIV continues it's upward move. We are getting awfully close to FDA approval of GMP facility and clinical trials on first 5 humans. Humanitarian use already filed. If human trials are as successful as primates this stock will be explosive.